Figure S6 from Copper Chelation as Targeted Therapy in a Mouse Model of Oncogenic BRAF-Driven Papillary Thyroid Cancer
Year: 2023
Type: other
Abstract: Reduction in MAPK signaling of BCPAP cells treated with vemurafenib and TM.
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361818432